Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and leuprolide

cetylpyridinium chloride anhydrous has been researched along with leuprolide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bailey, JN; Bowers, CY; Erickson, D; Hudson, SB; Reynolds, GA; Veldhuis, JD1
Bowers, CY; Miles, JM; Norman, C; Veldhuis, JD1

Trials

2 trial(s) available for cetylpyridinium chloride anhydrous and leuprolide

ArticleYear
Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women.
    American journal of physiology. Endocrinology and metabolism, 2009, Volume: 297, Issue:2

    Topics: Adolescent; Adult; Aged; Aging; Estradiol; Female; Gonadotropin-Releasing Hormone; Health; Human Growth Hormone; Humans; Intra-Abdominal Fat; Leuprolide; Middle Aged; Placebos; Pulsatile Flow; Young Adult

2009
Sex steroids, GHRH, somatostatin, IGF-I, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men.
    The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:12

    Topics: Age Factors; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Ghrelin; Gonadal Steroid Hormones; Growth Hormone-Releasing Hormone; Health; Human Growth Hormone; Humans; Infusions, Intravenous; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Leuprolide; Male; Middle Aged; Placebos; Pulsatile Flow; Somatostatin

2012